This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Global Neurostimulation Industry

NEW YORK, Dec. 5, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Global Neurostimulation Industry

http://www.reportlinker.com/p098270/Global-Neurostimulation-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Equipment_and_Supply

This report analyzes the Global markets for Neurostimulation in US$ Million by the following Product Segments: Spinal Cord Stimulators (SCS) {Radio Frequency (RF) System, Implantable Pulse Generator (IPG)}, Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), and Vagus Nerve Stimulators (VNS). The US market is analyzed both in terms of value (US$) and Volume (Units) for all the above listed Product Segments, and also additionally for Gastric Electric Stimulators (GES). The report provides separate comprehensive analytics for the United States, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. The report profiles 21 companies including many key and niche players such as Boston Scientific Corp., Cyberonics, Inc., Medtronic, Inc., St. Jude Medical, Inc., Synapse Biomedical, Inc., and SPR Therapeutics, LLC. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONSStudy Reliability and Reporting Limitations I-1Disclaimers I-2Data Interpretation & Reporting Level I-2Quantitative Techniques & Analytics I-3Product Definitions and Scope of Study I-3Spinal Cord Stimulation (SCS) I-3Radio Frequency (RF) Systems I-4Implantable Pulse Generator Systems (IPGs) I-4Deep Brain Stimulation (DBS) I-4Sacral Nerve Stimulation (SNS) I-4Vagus Nerve Stimulation (VNS) I-4II. EXECUTIVE SUMMARY

1. MARKET SNAPSHOTS II-1

2. MARKET OVERVIEW II-2Rising Demand for Neurostimulation Devices II-2Current and Future Analysis II-3Table 1: Worldwide Neurostimulation Market (2010-2018):Product Segments (Spinal Cord Stimulators, Deep BrainStimulators, Sacral Nerve Stimulators, and Vagus NerveStimulators) Ranked by Growth (includes correspondingGraph/Chart) II-4Neurostimulation Therapy Gets Popular II-5Technological Advancements So Far II-5SCS - The New Painkiller II-5Future Prospects II-5Obesity Control to Spur Market Growth in Future II-6Major Neurostimulation Therapies And Indications At A Glance II-7

1 of 11

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs